Su Lu

85 Wujin Road
Shanghai, 200080, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

SUMO1 promotes malignancy and chemoresistance in colorectal cancer: Clinical and functional evidence.

SUMO1 promotes malignancy and chemoresistance in colorectal cancer: Clinical and functional evidence.

Journal: Tissue & cell
Published: July 07, 2025

Dual roles of TRIM3 in colorectal cancer by retaining p53 in the cytoplasm to decrease its nuclear expression.

Dual roles of TRIM3 in colorectal cancer by retaining p53 in the cytoplasm to decrease its nuclear expression.

Journal: Cell death discovery
Published: October 07, 2022

HOXA10 induces BCL2 expression, inhibits apoptosis, and promotes cell proliferation in gastric cancer.

HOXA10 induces BCL2 expression, inhibits apoptosis, and promotes cell proliferation in gastric cancer.

Journal: Cancer medicine
Published: January 17, 2019

Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway.

Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway.

Journal: Journal of cancer research and clinical oncology
Published: January 11, 2018

HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5-FU resistance by a p53-dependent pathway.

HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5-FU resistance by a p53-dependent pathway.

Journal: Molecular carcinogenesis
Published: October 08, 2017

The chromatin-remodeling enzyme BRG1 promotes colon cancer progression via positive regulation of WNT3A.

The chromatin-remodeling enzyme BRG1 promotes colon cancer progression via positive regulation of WNT3A.

Journal: Oncotarget
Published: June 15, 2016

A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers.

A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers.

Journal: Scientific reports
Published: January 26, 2016

Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.

Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.

Journal: Journal of experimental & clinical cancer research : CR
Published: November 03, 2015

Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.

Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: September 01, 2015

Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.

Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.

Journal: European journal of cell biology
Published: July 02, 2015

Developmental pluripotency-associated 4: a novel predictor for prognosis and a potential therapeutic target for colon cancer.

Developmental pluripotency-associated 4: a novel predictor for prognosis and a potential therapeutic target for colon cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: February 18, 2015

Secernin-1 contributes to colon cancer progression through enhancing matrix metalloproteinase-2/9 exocytosis.

Secernin-1 contributes to colon cancer progression through enhancing matrix metalloproteinase-2/9 exocytosis.

Journal: Disease markers
Published: October 21, 2014
Showing 1-12 of 20

Last Updated: 09/26/2026